Hold TXN at $279 basis; $269 stop intact; deploy fresh capital only on confirmed $292 close with volume and MACD cross
Hold TXN at $279 entry with $269 hard stop. Do not deploy fresh capital at current prices (27x forward P/E, PEG 1.24, no margin of safety) given broken trend structure, four failed 50 SMA tests, and negative MACD. The tiered re-engagement protocol (measured add only on confirmed $292 close with volume and MACD cross; full Overweight reset on soft September CPI + breakout) provides the disciplined framework for rebuilding exposure after a new basing pattern establishes. Honor the $269 stop as a thesis-damaging event, not a tactical add opportunity.
| Position | Action |
|---|---|
| Price below $292 | No fresh capital deployment; hold existing position |
| Confirmed close above $292 with above-average volume and MACD line crossing positive | Measured add |
| Soft September CPI data plus breakout confirmation | Full reset to Overweight |
| Test of $269 stop | Honor stop; do not convert into add opportunity |
TXN is a fortress cash compounder in the early innings of a multi-year FCF expansion, with cyclical recovery accelerating, CapEx dramatically rolling off, and multiple industrial reshoring catalysts ahead.
| Indicator | Value | Signal |
|---|---|---|
| Close | $281.24 | neutral |
| 10 EMA | $280.38 | bullish |
| 50 SMA | $292.48 | bearish |
| 200 SMA | $227.97 | bullish |
| MACD | -3.68 | bearish |
| MACD Signal | -4.53 | bearish |
| MACD Histogram | +0.84 | bullish |
| RSI | 47.84 | neutral |
| ATR | $11.67 | neutral |
| Bollinger Lower Band | $266.76 | bullish |
| Bollinger Upper Band | $296.44 | bearish |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Soft September CPI plus breakout confirmation
Then: Reset to Overweight rating
CapEx has collapsed 60% YoY, creating massive FCF inflection point
↩ rebuts: “Bear concern about capital intensity and valuation”
EV: +18% · concedes: Bear is correct that TTM P/E of 42.7x appears elevated; Technical resistance at 50 SMA ($292.48) exists near current levels; Q2 2026 EPS annualizing to $8.56 trails consensus $10.40 estimate
TXN is a cyclical at peak-cycle multiples masquerading as a secular compounder; the recovery is easy comps off a trough, CapEx cuts signal demand plateau, the technical setup shows distribution not accumulation, and the macro backdrop of hawkish Fed and late-cycle cracks makes the 4:1 downside-to-upside skew the real risk/reward.
· concedes: Q2 2026 revenue did grow 22.8% YoY off a trough; CapEx did decline 60% YoY, expanding FCF in the near term; GE Appliances relationship is real and incremental; Stock holding above 200 SMA at $228
→ vs conservative: 27x forward P/E and PEG of 1.24 are not alarm bells; 58% earnings growth makes 1.24 PEG almost cheap. Anchoring to 52-week highs while ignoring the earnings trajectory.
→ vs conservative: DCF model assumes decelerating recovery, but CapEx declining for five straight quarters, GE Appliances nearly doubling chip spend, and Zacks adding to #1 Strong Buy list suggest accelerating fundamentals.
→ vs neutral: Waiting for close above $292 on volume means buying 10% higher entry after the breakout, destroying returns like the pattern that hurt retail for the last decade.
→ vs neutral: MACD histogram expanding +0.57 to +0.84 and MACD line rising -6.00 to -3.68 shows momentum recovery already in motion, not requiring waiting for confirmation.
→ vs neutral: Four failed tests of declining 50 SMA were on the way down from $332, a basing pattern with higher lows, not a topping pattern.
→ vs conservative: In a hawkish-but-no-recession regime (86% zero cut probability), analog defensive compounders get rewarded for years, not months.
| 52-Week Peak | $332.33 (June 22, 2026) | bearish |
| RSI Peak | 77.15 (May 26, 2026) | bearish |
| ATR Peak | $15.35 (July 8) | bearish |
Support: 266.76 · 269.04 · 275 · 280.38 | Resistance: 292.48 · 296.44 · 300
TXN is in a neutral-to-cautiously-bullish consolidation following a 15.3% correction from the $332.33 June peak. Long-term trend remains intact (200 SMA rising at $227.97, price +53 above), but medium-term weakness persists (50 SMA declining at $292.48, price -$11 below). Early-stage momentum recovery is underway: MACD histogram has turned positive (+0.84 from -3.21 on Jun 29), MACD line is rising (Jul 31: -6.00 to -3.68), and RSI has recovered from near-oversold 38 to neutral 47.84. Volatility is compressing (ATR $11.67 down from $15.35 peak), indicating selling pressure is easing. Key inflection at $292.50 (50 SMA): bullish confirmation requires decisive close above on rising volume; bearish breakdown below $269 exposes $266.76 Bollinger lower band.
Market Cap
$256.84B
P/E (TTM)
42.68x
Forward P/E
27.03x
PEG Ratio
1.24
Price / Book
14.26x
EV / EBITDA (est.)
~28x
Dividend Yield
2.03%
Beta
1.325
52-Week High
$334.03
52-Week Low
$152.73
50-Day MA
$294.24
200-Day MA
$229.61
Revenue (TTM)
$19.45B
Gross Profit
$11.35B
EBITDA
$9.52B
Net Income
$6.02B
Operating Margin
42.6%
ROE
35.18%
ROA
13.06%
Free Cash Flow (TTM)
$3.55B
Diluted EPS (TTM)
$6.59
Forward EPS (Consensus Est.)
$10.40
Q2 2026 Revenue
$5,463M
Q2 2026 Gross Margin
61.4%
Q2 2026 Operating Margin
42.6%
Q2 2026 Diluted EPS
$2.14
Q2 2026 Free Cash Flow
$2,189M
Q2 2026 CapEx
$514M
Cash & ST Investments (Q2 2026)
$7,001M
Total Assets (Q2 2026)
$35.88B
Long-Term Debt (Q2 2026)
$12,903M
Total Debt (Q2 2026)
$14,052M
Net Debt (Q2 2026)
$10,392M
Stockholders' Equity (Q2 2026)
$18,007M
Current Ratio (Q2 2026)
4.86x
Inventory (Q2 2026)
$4,605M
Net PP&E (Q2 2026)
$11,911M
Net Debt / EBITDA
~1.1x
Annual Dividends
~$5.2B
YoY Revenue Growth (Q2 2026)
+22.8%
YoY EPS Growth (Q2 2026)
+51.8%
YoY FCF Growth (Q2 2026)
+294%
CapEx Trajectory
Declining 5 consecutive quarters
2025 Revenue
$17.68B
2024 Revenue
$15.64B
2021 Revenue
$20.03B
2025 Diluted EPS
$5.45
2024 Diluted EPS
$5.20
2021 Diluted EPS
$9.41
Strengths
Concerns
Texas Instruments is a high-quality cyclical semiconductor franchise with best-in-class profitability (42.6% operating margin, 58.3% gross margin) that is currently in early-stage recovery from a pronounced 2023-2024 downturn. Q2 2026 demonstrated accelerating momentum with revenue growth of +22.8% YoY and EPS growth of +51.8% YoY, while CapEx declined 60.6% YoY enabling FCF to nearly quadruple to $2.19B. With the multi-year fab build-out largely complete and CapEx rolling toward $1-1.5B annually, the company is positioned to generate $10B+ annual FCF by 2027. The stock trades near its 52-week high at a forward P/E of ~27x with a 2.03% dividend yield, offering a balanced risk/reward for new positions while existing holders benefit from the strong fundamental tailwinds. Key risks include geopolitical exposure in China, cyclical semiconductor volatility, and premium valuation that leaves little room for execution disappointments.
Macro: Hawkish-but-not-recessionary regime: 86% probability of zero Fed rate cuts in 2026 (Polymarket), 8% US recession probability (fading lower). Market is pricing out rate-cut tails, not in. Broad tape is cautious and defensive—stocks fading two consecutive sessions, pre-CPI caution dominating. Oil climbing on geopolitical risk (US-Iran deal doubts). This is a late-cycle, soft-landing-with-wobbles backdrop—not a recession, not a melt-up. Historically supportive for boring, high-free-cash-flow compounders like TXN; challenging for high-multiple speculative chip names.